TABLE 4.
Relative abundance of amino acids and derivatives in cumulus cells. Cumulus cells were collected from young mares (Yg, n = 8) and old mares (Old, n = 6) at 0 h (GV, germinal vesicle stage) or 24 h (MI, metaphase I stage) after maturation induction, with additional oocytes collected as 24 h and cultured in vitro for an additional 18 h (MIIC, metaphase II stage after culture). Results are presented as mean ± SEM and correction factor of 10x (CF). p-values for the main effect of stage (MS) and the interaction (INT) of stage-by-age are included in the table; the main effect of age was not significant (p > 0.05) for any of the metabolites. Different superscripts within a row represent differences at a,b,c p < 0.05 or d,e,f p < 0.1. Superscripts within a column for the same metabolite represent differences between Yg and Old at * p < 0.05 or + p < 0.1.
| Amino acids and derivatives | Age | GV | MI | MIIC | CF | MS | INT |
|---|---|---|---|---|---|---|---|
| α-ketobutyrate | Yg | 1.57 ± 0.18a | 22.20 ± 3.37b | 34.26 ± 6.20b | 103 | <0.001 | 0.24 |
| Old | 1.95 ± 0.23a | 18.60 ± 3.39b | 21.17 ± 3.10b | ||||
| Alanine | Yg | 12.11 ± 0.93a | 8.09 ± 1.36a | 31.54 ± 3.52b,+ | 106 | <0.001 | 0.04 |
| Old | 11.59 ± 2.27ab | 8.33 ± 1.50a | 21.69 ± 2.27b,+ | ||||
| Cysteine | Yg | 1.75 ± 0.27ab,d | 1.43 ± 0.16a | 5.04 ± 1.03b,e | 105 | 0.01 | 0.45 |
| Old | 1.29 ± 0.11 | 1.55 ± 0.38 | 7.36 ± 3.35 | ||||
| Cysteinyl-Proline | Yg | 5.38 ± 2.38 | 2.65 ± 1.24 | 140.09 ± 55.80 | 102 | 0.01 | 0.31 |
| Old | 6.78 ± 2.74a | 3.42 ± 1.15a | 70.54 ± 18.28b | ||||
| ɛ-polylysine | Yg | 54.52 ± 26.91de | 103.39 ± 29.28d | 9.41 ± 4.83e | 103 | <0.01 | 0.86 |
| Old | 38.11 ± 23.96 | 89.00 ± 21.74 | 15.32 ± 13.03 | ||||
| Glutamic acid | Yg | 5.22 ± 0.44a,* | 7.36 ± 0.93a,* | 85.24 ± 9.21b | 105 | <0.001 | 0.76 |
| Old | 11.36 ± 3.08a,* | 15.20 ± 3.27b,d,* | 85.80 ± 21.33b,e | ||||
| Glycine (3TMS) | Yg | 2.84 ± 0.12a | 2.35 ± 0.16a,+ | 7.71 ± 0.54b | 107 | <0.001 | 0.07 |
| Old | 2.81 ± 0.10a | 3.12 ± 0.42a,+ | 6.39 ± 0.79b | ||||
| Glycine (2TMS) | Yg | 6.76 ± 0.54a,* | 6.69 ± 0.32a | 2.70 ± 0.42b | 107 | <0.001 | 0.20 |
| Old | 4.97 ± 0.62ab,d,* | 5.25 ± 0.84a | 2.61 ± 0.76b,e | ||||
| Glycyl-tyrosine | Yg | 71.47 ± 26.08ab | 98.31 ± 20.53a | 4.44 ± 1.90b | 104 | <0.001 | 0.47 |
| Old | 45.70 ± 21.6a | 116.89 ± 15.65b | 25.70 ± 23.36ab | ||||
| Pyroglutamic acid | Yg | 5.32 ± 1.67a | 5.49 ± 0.70a | 91.45 ± 4.37b | 106 | <0.001 | 0.18 |
| Old | 5.49 ± 0.72a | 18.53 ± 9.52a | 81.82 ± 16.20b | ||||
| Serine | Yg | 2.92 ± 0.86a | 1.09 ± 0.37a | 7.90 ± 0.53b | 106 | 0.01 | 0.32 |
| Old | 3.02 ± 1.31 | 4.16 ± 3.30 | 6.93 ± 1.21 | ||||
| Threonine | Yg | 4.82 ± 1.39a | 3.05 ± 0.35a | 50.94 ± 4.69b | 105 | <0.001 | 0.17 |
| Old | 3.60 ± 0.65a | 7.80 ± 4.07a | 40.51 ± 8.34b |